CD44 and breast carcinoma: The shortest CD44 isoform (CD44s) was found to inhibit breast cancer stemness, and the cleaved product of CD44 (CD44ICD) promoted breast cancer stemness,40 while nuclear CD44 in liver cancer stem cells is responsible for the poorly differentiated highly malignant tumor cells by maintenance of low stemness state.41